The press conference organized by UNIC partner National Agency on Corruption Prevention

23 november, 2022

On Friday, November 18, during the press conference organized by UNIC partner National Agency on Corruption Prevention, new research, "Corruption risks during restrictions on the circulation of medicinal products under martial law," was presented regarding the Law of Ukraine "On Amendments to The Law of Ukraine "On Medicinal Products" adopted by the Verkhovna Rada of Ukraine on May 22, 2022, as well as several by-laws that were developed for its implementation.

 The declared purpose of this Law is to limit the circulation of medicinal products in Ukraine, the production of which is at least partially located in the russian federation or belarus, and to have the world refuse such supplies. At the same time, contrary to its purpose, the Law contained too broad criteria to limit the circulation of almost any medicines produced in European and other countries that are not directly related to the aggressor countries.

 Lana Sinichkina, UNIC Executive Committee member and head of Arzinger's healthcare and pharmaceutical practice, presented the UNIC pharmaceutical group position during the press conference and spoke in detail about the corruption risks hidden in the Law: "The legislative initiative itself contained several corruption factors from the very beginning. These risks cannot be minimized. Therefore our position is to develop and amend the Law of Ukraine "On Medicinal Products" to bring its name and the declared purpose of the content of the relevant norms it establishes. It is necessary to eliminate the prerequisites for the manual mechanism of filtering the medicinal products market in favor of someone's commercial interests."

 UNIC welcomes the results of the NAPC research because, as part of the UNIC pharmaceutical group activities, experts worked out the legislative initiatives of the Ministry of Health on this issue and sent UNIC's position to the competent authorities regarding corruption risks, monopolization risks, potential threats to the patients’ lives and losses to the economy of Ukraine in case of these initiatives implementation.

You can read more about the NAPC recommendations in research at the link

 View the research presentation online: